Bile fibronectin in biliary stricture diagnosis

Detalhes bibliográficos
Autor(a) principal: Ornellas, Laura Cotta
Data de Publicação: 2006
Outros Autores: Nakao, Frank Shigueo, Rohr, Maria Rachel da Silveira, Leite-Mor, Marilisa Moraes Barros, Parise, Edison, Ferrari, Angelo Paulo
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1846
Resumo: Background: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures.
id INCA-1_08cc1e2d7a24a044173460e9d205013f
oai_identifier_str oai:rbc.inca.gov.br:article/1846
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Bile fibronectin in biliary stricture diagnosisFibronectina biliar no diagnóstico de estenoses biliaresBilePancreatocolangiografiaFibronectinaIcteríciaBileCholangiopancreatographyFibronectinJaundiceBackground: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures.Introdução: Ainda, não existe método ideal para o diagnóstico diferencial entre estenoses biliares malignas e benignas. Este estudo visa a comparar a concentração de fibronectina biliar nos pacientes com e sem estenose biliar maligna. Métodos: Durante a pancreatocolangiografia retrógrada endoscópica (PCRE), foram coletadas amostras de bile de 50 pacientes com estenose biliar extra-hepática maligna (40), benigna (10) e de 10 doentes sem estenose biliar (grupo controle). A fibronectina total na bile foi determinada por ensaio imunoenzimático. A concentração sérica de bilirrubina direta, fosfatase alcalina, gama glutamiltransferase, aspartato aminotransferase e alanina aminotransferase foi determinada nos pacientes com estenose biliar antes da PCRE. O diagnóstico final foi definido por cirurgia, biópsia ou acompanhamento clínico. Resultados: Os pacientes com neoplasia maligna eram significativamente mais idosos (p= 0,02) e apresentaram níveis mais elevados dos testes bioquímicos relacionados à colestase (p< 0,01). Não houve diferença significativa na concentração de fibronectina biliar entre os pacientes com estenose maligna (694,2 ± 823,5 ng/ml), benigna (828,9 ± 925ng/ml) e grupo controle (466,5 ± 621,5 ng/ml), ou entre os pacientes com (721,2 ± 836,6 ng/ml) e sem estenose (466,5 ± 621,5 ng/ml). Conclusões: As médias de idade e de resultados de exames laboratoriais relacionados à colestase foram mais elevadas nos pacientes com neoplasia maligna. A dosagem apenas da fibronectina total na bile não foi eficaz para diagnóstico diferencial das estenoses biliares.INCA2006-12-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/184610.32635/2176-9745.RBC.2006v52n4.1846Revista Brasileira de Cancerologia; Vol. 52 No. 4 (2006): Oct.Nov./Dec.; 331-335Revista Brasileira de Cancerologia; Vol. 52 Núm. 4 (2006): oct./nov./dic.; 331-335Revista Brasileira de Cancerologia; v. 52 n. 4 (2006): out./nov./dez.; 331-3352176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/1846/1121Ornellas, Laura Cotta Nakao, Frank Shigueo Rohr, Maria Rachel da Silveira Leite-Mor, Marilisa Moraes Barros Parise, Edison Ferrari, Angelo Paulo info:eu-repo/semantics/openAccess2021-11-29T20:27:27Zoai:rbc.inca.gov.br:article/1846Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:27:27Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Bile fibronectin in biliary stricture diagnosis
Fibronectina biliar no diagnóstico de estenoses biliares
title Bile fibronectin in biliary stricture diagnosis
spellingShingle Bile fibronectin in biliary stricture diagnosis
Ornellas, Laura Cotta
Bile
Pancreatocolangiografia
Fibronectina
Icterícia
Bile
Cholangiopancreatography
Fibronectin
Jaundice
title_short Bile fibronectin in biliary stricture diagnosis
title_full Bile fibronectin in biliary stricture diagnosis
title_fullStr Bile fibronectin in biliary stricture diagnosis
title_full_unstemmed Bile fibronectin in biliary stricture diagnosis
title_sort Bile fibronectin in biliary stricture diagnosis
author Ornellas, Laura Cotta
author_facet Ornellas, Laura Cotta
Nakao, Frank Shigueo
Rohr, Maria Rachel da Silveira
Leite-Mor, Marilisa Moraes Barros
Parise, Edison
Ferrari, Angelo Paulo
author_role author
author2 Nakao, Frank Shigueo
Rohr, Maria Rachel da Silveira
Leite-Mor, Marilisa Moraes Barros
Parise, Edison
Ferrari, Angelo Paulo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ornellas, Laura Cotta
Nakao, Frank Shigueo
Rohr, Maria Rachel da Silveira
Leite-Mor, Marilisa Moraes Barros
Parise, Edison
Ferrari, Angelo Paulo
dc.subject.por.fl_str_mv Bile
Pancreatocolangiografia
Fibronectina
Icterícia
Bile
Cholangiopancreatography
Fibronectin
Jaundice
topic Bile
Pancreatocolangiografia
Fibronectina
Icterícia
Bile
Cholangiopancreatography
Fibronectin
Jaundice
description Background: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures.
publishDate 2006
dc.date.none.fl_str_mv 2006-12-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1846
10.32635/2176-9745.RBC.2006v52n4.1846
url https://rbc.inca.gov.br/index.php/revista/article/view/1846
identifier_str_mv 10.32635/2176-9745.RBC.2006v52n4.1846
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1846/1121
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 52 No. 4 (2006): Oct.Nov./Dec.; 331-335
Revista Brasileira de Cancerologia; Vol. 52 Núm. 4 (2006): oct./nov./dic.; 331-335
Revista Brasileira de Cancerologia; v. 52 n. 4 (2006): out./nov./dez.; 331-335
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042248187117568